Use of inhibitors of the renin-angiotensin system
US7071183B2 · kind B2 · utility
1Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2002 |
| Grant date | Jul 4, 2006 |
| Priority date | — |
| Expiry date | Jul 26, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G61/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
It has been found that inhibitors of the renin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.